TrialCNS drugs2023

Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis.

Tammy Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.